Roche (RHHBY) Purchases Shares of Memory Pharmaceuticals (MEMY) in Tender Offer
Up)
Roche (OTC: RHHBY) announced that its wholly-owned subsidiary 900 North Point Acquisition Corporation has accepted for payment all shares validly tendered and not withdrawn pursuant to its tender offer for all outstanding shares of common stock of Memory Pharmaceuticals Corp. (Nasdaq: MEMY) at $0.61 per share in cash.
As of the expiration of the tender offer, a total of approximately 73,169,195 shares of Memory common stock were tendered and not withdrawn (including approximately 890,630 shares tendered by delivery of notices of guaranteed delivery), representing approximately 89% of Memory's outstanding shares.
Roche Holding Ltd. (Roche) is a Switzerland-based pharmaceuticals and a diagnostics company. Roche belongs to the Roche Group that operates through various subsidiaries and associated companies located worldwide. [SM]
As of the expiration of the tender offer, a total of approximately 73,169,195 shares of Memory common stock were tendered and not withdrawn (including approximately 890,630 shares tendered by delivery of notices of guaranteed delivery), representing approximately 89% of Memory's outstanding shares.
Roche Holding Ltd. (Roche) is a Switzerland-based pharmaceuticals and a diagnostics company. Roche belongs to the Roche Group that operates through various subsidiaries and associated companies located worldwide. [SM]
You May Also Be Interested In
- UPDATE: Angelo, Gordon to Acquire Benihana (BNHN) for $16.30/Share in Cash
- General Mills (GIS) to Double LatAm Sales w/ New Brazilian Acquisition
- China Investment may nab $2B stake in Alibaba - Reuters
Create E-mail Alert Related Categories
Mergers and AcquisitionsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
